Status: Not yet recruiting
A Study on the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of SHR-7012 in Healthy Adults
A Study on the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of SHR-7012 in Healthy Adults
Participants needed: 50
Trial details
Phase: Phase 1Age: 18-55Biological sex: AllType: InterventionalSponsor: Guangdong Hengrui Pharmaceutical Co., LtdUpdated: Aug 6, 2026Locations: 1
Eligibility criteria
The age of signing the informed consent form was between 18 and 55 years old (in... [+4]
Patients with previous or current clinical acute or chronic diseases of the circ... [+14]